A study showed that high expression of Lilrb2 was identified in patients with myocardial infarction [51, 52], and downregulated Lilrb2 could visibly improve cardiomyocyte injury by regulating cell activity and apoptosis [52]. The gene discussed is LILRB2; the disease is myocardial infarction.